Literature DB >> 23073318

Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.

Mao-Song Tsai1, Chien-Ching Hung1, Wen-Chun Liu1, Kuan-Lin Chen2, Mao-Yuan Chen1, Szu-Min Hsieh1, Wang-Huei Sheng1, Hsin-Yun Sun1, Tiffany T F Shih3.   

Abstract

BACKGROUND: Reduced bone mineral density (BMD) is an emerging threat to the successful long-term management of human immunodeficiency virus (HIV) infection among patients with access to combination antiretroviral therapy (cART). Data on the prevalence and associated factors of reduced BMD in Asian populations remain scarce.
METHODS: From March 2002 to April 2006, a cross-sectional survey was conducted among HIV-infected patients aged ≥ 20 years at the National Taiwan University Hospital. BMD of the lumbar spine was measured with the use of dual-energy X-ray absorptiometry. Osteopenia was defined as a BMD T-score between -1.0 and -2.5, and osteoporosis was defined as a BMD T-score ≤ -2.5. Linear and ordinal logistic regression analyses were performed.
RESULTS: Among 320 patients with a median age of 37.3 years, body mass index (BMI) of 21.4kg/m(2) and 94.4% on cART, osteopenia and osteoporosis were diagnosed in 35.6% and 3.8%, respectively. On multivariate linear analysis, factors associated with reduced BMD were increasing age (p=0.006), longer duration on antiretroviral therapy (p=0.007), and a decreasing BMI (p=0.002). Using ordinal logistic regression, being underweight with a body mass index (BMI)<18.5kg/m(2) was independently associated with reduced BMD (proportional odds ratio, 4.12; 95% confidence interval, 1.93-8.82).
CONCLUSION: Reduced BMD was prevalent among HIV-infected Taiwanese adults on cART. Increased age, lower BMI, and exposure to antiretroviral therapy were significantly associated with decrease of BMD.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  Antiretroviral therapy; Body mass index; Bone mineral density; HIV; Prevalence

Mesh:

Year:  2012        PMID: 23073318     DOI: 10.1016/j.jmii.2012.08.026

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

Review 1.  Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.

Authors:  Anna C Hearps; Genevieve E Martin; Reena Rajasuriar; Suzanne M Crowe
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

Review 2.  Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.

Authors:  Huan V Dong; Yamnia I Cortés; Stephanie Shiau; Michael T Yin
Journal:  AIDS       Date:  2014-09-10       Impact factor: 4.177

3.  Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan.

Authors:  Pei-Ying Wu; Mao-Yuan Chen; Szu-Min Hsieh; Hsin-Yun Sun; Mao-Song Tsai; Kuan-Yeh Lee; Wen-Chun Liu; Shan-Ping Yang; Yu-Zhen Luo; Jun-Yu Zhang; Wang-Huei Sheng; Chien-Ching Hung
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

4.  Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysis.

Authors:  Zi-Yi Jin; Xing Liu; Ying-Ying Ding; Zuo-Feng Zhang; Na He
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

5.  Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy.

Authors:  Mao-Song Tsai; Jun-Yu Zhang; Hsin-Yun Sun; Wen-Chun Liu; Pei-Ying Wu; Chia-Jui Yang; Chien-Ching Hung
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

6.  High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy.

Authors:  Pyoeng Gyun Choe; Hyung Jin Choi; Nak-Hyun Kim; Wan Beom Park; Kyoung-Ho Song; Ji Hwan Bang; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Myoung-don Oh; Nam Joong Kim
Journal:  J Int AIDS Soc       Date:  2014-01-09       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.